🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Alcohol Use Disorder (AUD)

Suvorexant for Treatment of AUD and PTSD NCT06679062Phase 22 sites📍 Los Angeles📍 Houston Pharmacotherapies for Alcohol and Substance Use Disorders A… · Tests: Suvorexant, Placebo LSD Treatment for Persons With Alcohol Use Disorder NCT05474989Phase 22 sites📍 Basel📍 Bern Felix Mueller · Tests: LSD, Active placebo Study of Tirzepatide for Recovery and Alcohol Use Management NCT06727331Phase 22 sites📍 Boston📍 Jamaica Plain Brigham and Women's Hospital · Tests: Tirzepatide, Saline Placebo Naltrexone in AUD Reward Drinkers NCT05028062Phase 41 site📍 Philadelphia University of Pennsylvania · Tests: XR-NTX 380 mg, intramuscular injection, Medical Management, Placebo intramuscular injection Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder NCT06949423NA1 site📍 Palo Alto Stanford University · Tests: Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Active, Deep Transcranial Magnetic Stimulation (dTMS) H7 coil -… Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma NCT06278922NA1 site📍 Worcester University of Massachusetts, Worcester · Tests: Seeking Safety + Signs of Safety toolkit, Treatment as usual LGG Supplementation in Patients With AUD and ALD NCT05178069Phase 21 site📍 Louisville University of Louisville · Tests: : Placebo for Probiotic, Lactobacillus Rhamnosus GG Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms NCT06484075Phase 1, Phase 21 site📍 Bethesda National Institute on Alcohol Abuse and Alcoholism (NIAAA) · Tests: Siemens 3T PRISMA MR Scanner, PET/CT Scanner, Suvorexant, Placebo Role of Pavlovian Mechanisms for Control Over Substance Use NCT06701487n/a1 site📍 Dresden Technische Universität Dresden · Tests: fMRI imaging (BOLD), sMRI (structure), Pavlovian-to-instrumental transfer (PIT) paradigm, Basic psychological assessmen… Virtual Reality (VR) NATURE - Alcohol Use Disorder (AUD) NCT07413458NA1 site📍 Ann Arbor University of Michigan · Tests: Virtual Reality (VR) -nature treatment, Survey completion Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder NCT06969937Phase 21 site📍 Zurich Dr. med. Marcus Herdener · Tests: Ketamine, Real-time fMRI Neurofeedback Training, Placebo, Sham Neurofeedback Training/ Ketamine Anxiety During Abstinence in AUD NCT06793488EARLY Phase 11 site📍 New York Columbia University · Tests: Disulfiram 250 mg, functional MRI Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide NCT07040592Phase 21 site📍 Decatur Yale University · Tests: semaglutide Neural and Hormonal Influences on Sex Differences in Risk for AUD NCT04929288NA1 site📍 Columbus Jessica Weafer · Tests: Alcohol Imaging CRF X NOP Interactions in Alcohol Use Disorder NCT07612631EARLY Phase 11 site📍 Pittsburgh Rajesh Narendran · Tests: Baseline [C-11]NOP-1A PET scan, Hydrocortisone, Post-hydrocortisone [C-11]NOP-1A PET scan PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder NCT06795581Phase 11 site📍 Bethesda National Institute of Mental Health (NIMH) · Tests: 18F-PF-06445974 TRIS: Contingency Management App for Alcohol Use Disorder NCT07735585NA1 site📍 São Paulo University of Sao Paulo General Hospital · Tests: Remote Contingency Management (CM), Treatment as Usual (TAU) Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD) NCT07525258NA1 site📍 New Haven Yale University · Tests: Implementation Intervention Deep Brain Stimulation to Understand and Treat Addiction NCT07341230NA2 sites📍 Cambridge📍 London University of Cambridge · Tests: Dual-Target Deep Brain Stimulation, Nucleus Accumbens Deep Brain Stimulation, Ventral Internal Capsule Deep Brain Stimu… Developing a Novel Human Laboratory Paradigm for AUD Medication Screening NCT06489782NA1 site📍 New Haven Yale University · Tests: Model 1, Model 2 Web-based Alcohol- or Cocaine-specific Inhibition Training in Adolescents and Young Adults With Substance Use Disorder NCT07071779NA1 site📍 Bern University of Bern · Tests: Substance-specific inhibition training, Control training Imaging Phosphodiesterase 4B (PDE4B) in People With Psychiatric Disorders With Positron Emission Tomography (PET) and the Radiotracer [18F]PF974 NCT07488819n/a1 site📍 New Haven Yale University · Tests: PF974 Assessing Habitual, Goal-Directed, and Pavlovian Influences in Alcohol Use Disorder NCT06701500n/a1 site📍 Dresden Technische Universität Dresden · Tests: Pavlovian-to-instrumental transfer (PIT) paradigm, Action Sequence Task (AST), Basic psychological assessment (intervie… Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study NCT06335407Phase 11 site📍 West Haven Pharmacotherapies for Alcohol and Substance Use Disorders A… · Tests: Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 40µg, Dexmedetomidine (DEX) for sublingual (SL) ad… Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking NCT05181891Phase 21 site📍 Spokane Washington State University · Tests: Contingency Management, Non-contingent control Virtual Incentive Treatment for Alcohol NCT06265506NA1 site📍 Spokane Washington State University · Tests: Contingency Management, Computer Based Training for Cognitive Behavioral Therapy for AUD (CBT4CBT) Attentional Control Training for Treating Alcohol Use Disorder NCT05102942NA1 site📍 Valby University of Southern Denmark · Tests: Attentional Control Training Program Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients NCT06269510NA1 site📍 Detroit Henry Ford Health System · Tests: ENGAGE-ALD Application (APP), Treatment Facilitation bundle, Enhanced Usual Care Neural Correlates During Alcohol Intoxication NCT06118580Phase 21 site📍 Columbus Ohio State University · Tests: Alcohol (Ethanol), Placebo TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD) NCT07171359NA1 site📍 Portland Washington State University · Tests: TMS Low-Dose, TMS High-Dose
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy